Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Insights on the future of access to medicine: Mary Wambui Moehlmann to speak at IDA Monthly Meeting

Mary Wambui Moehlmann, Engagement Lead – LMICs at the Access to Medicine Foundation, will share her expertise as a guest speaker at the IDA’s monthly meeting on “The Future of Access to Medicine”. She will discuss the Foundation's engagement strategies with stakeholders from low- and middle-income countries (LMICs), highlighting efforts to improve medicine accessibility.

Date

20 July 2023

Date

20 July 2023

Location

Amsterdam, the Netherlands 

Format

In-person

Invited as a guest speaker at the IDA Foundation’s (IDA’s) monthly meeting, Mary Wambui Moehlmann, Engagement Lead – LMICs at the Access to Medicine Foundation (the Foundation), will provide insights into the Foundation's mission and objectives. Her focus will be on the collaboration between the Foundation and Ministries of Health, as well as local organisations in LMICs.  

During her presentation, Mary will provide updates on the Foundation's various programmes, including upcoming publications such as the Antimicrobial Resistance (AMR) Programme’s August 2023 report on responsible manufacturing and the Generic and Biosimilar Medicines Programme’s first set of generic and biosimilar company profiles.  

Mary’s insights will delve into the Foundation’s engagement strategies, which aim to strengthen collective efforts in enhancing healthcare access in LMICs. These strategies align with those of IDA, which aim to improve the supply chain for therapeutics and vaccines in resource-limited settings.  

Resource Centre

Explore our research reports and publications
Research

The 2023 Analytical Framework for the Generic & Biosimilar Medicines Programme

15 February 2023
Research

Lack of access to medicine is a major driver of drug resistance. How can pharma take action?

27 October 2022
Research

The Access to Medicine Foundation's Strategic Direction 2022-2026

14 December 2021

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved